Arcturus Therapeutics said it will attend SSIEM 2026 to discuss its mRNA medicines program for OTC deficiency. The company will exhibit at Booth S11 on Aug. 25-

BWB News TV • 2026-08-05 21:11 UTC • By Billy Odell Tucker-Robinson

Arcturus Therapeutics said it will attend SSIEM 2026 to discuss its mRNA medicines program for OTC deficiency. The company will exhibit at Booth S11 on Aug. 25-28, but disclosed no new data or research outcomes in the announcement.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly